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Abstract
Background: The persistent colonization of paranasal sinus mucosa by microbial biofilms is a major factor in the
pathogenesis of chronic rhinosinusitis (CRS). Control of microorganisms within biofilms is hampered by the presence of
viscous extracellular polymers of host or microbial origin, including nucleic acids. The aim of this study was to investigate
the role of extracellular DNA in biofilm formation by bacteria associated with CRS.
Methods/Principal Findings: Obstructive mucin was collected from patients during functional endoscopic sinus surgery.
Examination of the mucous by transmission electron microscopy revealed an acellular matrix punctuated occasionally with
host cells in varying states of degradation. Bacteria were observed in biofilms on mucosal biopsies, and between two and six
different species were isolated from each of 20 different patient samples. In total, 16 different bacterial genera were isolated,
of which the most commonly identified organisms were coagulase-negative staphylococci, Staphylococcus aureus and a-
haemolytic streptococci. Twenty-four fresh clinical isolates were selected for investigation of biofilm formation in vitro using
a microplate model system. Biofilms formed by 14 strains, including all 9 extracellular nuclease-producing bacteria, were
significantly disrupted by treatment with a novel bacterial deoxyribonuclease, NucB, isolated from a marine strain of Bacillus
licheniformis. Extracellular biofilm matrix was observed in untreated samples but not in those treated with NucB and
extracellular DNA was purified from in vitro biofilms.
Conclusion/Significance: Our data demonstrate that bacteria associated with CRS form robust biofilms which can be
reduced by treatment with matrix-degrading enzymes such as NucB. The dispersal of bacterial biofilms with NucB may offer
an additional therapeutic target for CRS sufferers.
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Introduction
Chronic rhinosinusitis (CRS) is one of the most common upper
respiratory tract diseases, affecting approximately 10% of the adult
European population [1]. Rhinosinusitis is an inflammation of the
paranasal sinuses that is almost always accompanied by in-
flammation of the nasal airway and is classified as ‘chronic’ if it
lasts at least 12 consecutive weeks [2]. The symptoms of CRS
include blockage or congestion of the nasal passages, nasal
discharge, facial pain or pressure and/or a reduction or loss of
sense of smell. The majority of cases of CRS are treated with
medical therapy consisting of topical steroids and nasal douching
[3]. Antibiotics such as clarithromycin or amoxicillin may be used
at the outset of therapy or for acute exacerbations of disease. In
cases of CRS that are recalcitrant to medical treatment, surgical
techniques may be warranted to improve the drainage pathway of
the sinuses and to remove polyps and obstructive mucin. Non-
invasive surgical interventions, known collectively as functional
endoscopic sinus surgery (FESS), are now widely used, although
there is limited evidence to support their efficacy [4]. The
successful treatment of CRS is hampered by the heterogeneity of
the disease. Chronic rhinosinusitis is a spectrum of diseases with
a variety of causes or contributing factors including smoking,
allergies, underlying systemic diseases, invasive or non-invasive
fungal infections, viruses and bacteria [2,5,6]. Increasingly, it is
becoming clear that microbial biofilms are associated with many
cases of CRS. The growth of microorganisms within biofilms
presents unique problems for the management of CRS. Within
biofilms, micro-organisms are up to 1,000-fold more resistant to
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antibiotics than free-living cells of the same species [7]. Increased
resistance is due to many factors, including the presence of
a viscous polymeric matrix that restricts the penetration of
antimicrobials, slow growth of bacteria, resistant phenotypes,
and altered chemical microenvironments [8–11]. In keeping with
these observations, there is limited evidence that either topical or
systemic antibiotics improve the outcome of CRS infections
[12,13] underlining the need for new therapeutic approaches.
The role of biofilms in the initiation of CRS and their
recalcitrance to treatment has received a great deal of attention
over the last few years. A recent review of the literature identified
11 studies reporting the analysis of biofilms on sinus mucosa in
CRS patients [14]. Several different techniques were employed to
visualise biofilms. Arguably the most convincing method was
fluorescence in situ hybridization, since this provides contrast
between bacterial DNA and host cells. Biofilms on mucosal
surfaces appear as punctate staining (bacterial cells), occasionally
with some diffuse coloration, suggestive of extracellular nucleic
acids [9]. All studies detected biofilms in a proportion of CRS
patients, with prevalence varying from 25% to 100%. In contrast,
only three of the eight studies that also analysed non-CRS controls
identified biofilms on the non-CRS sinus mucosa, and these
involved small numbers of patients. Collectively, these data clearly
point to an association between biofilms on sinus mucosa and
CRS. In addition, biofilms or biofilm-forming bacteria have been
associated with unfavourable outcomes following FESS. For
example, the presence of biofilms on paranasal sinus mucosa
was correlated with persistent mucosal inflammation and require-
ments for lengthy post-surgical follow-up periods [15]. In a large
cross-sectional study involving 518 CRS patients, the presence of
sinus biofilms was significantly correlated with prior experience of
sinus surgery, indicating either that biofilms contribute to CRS
recurrence, or that FESS may promote the formation of biofilms
[16]. Further, the capacity of paranasal sinus isolates of
Staphylococcus aureus or Pseudomonas aeruginosa to form biofilms in vitro
has been associated with the recurrence of CRS symptoms in the
12 month period following FESS [17].
There is strong evidence that the microflora of the maxillary
sinus changes during acute sinusitis, towards a predominance of
Streptococcus pneumoniae, Haemophilus influenzae and, less frequently,
Moraxella catarrhalis [18,19]. However, the microbial population
present in CRS more closely resembles that in non-inflamed
paranasal sinuses. The most common organisms both in CRS and
in healthy patients include Staphylococcus aureus, coagulase-negative
staphylococci, a-haemolytic streptococci, Corynebacterium spp. and
strict anaerobes such as Prevotella spp., Peptostreptococcus spp. and
Propionibacterium spp. [19–22]. Therefore, the development of
biofilms within the paranasal sinuses, and the subsequent host
responses to biofilms, may be more important for the pathogenesis
of CRS than the de novo colonization of the upper respiratory tract
by specific pathogens.
In light of the resistance of biofilm bacteria to conventional
antibiotics, a number of novel approaches for treating biofilms
have been proposed, including interfering with chemical commu-
nication between micro-organisms or degrading the biofilm matrix
with enzymes [23,24]. Biofilms associated with CRS are extremely
heterogeneous, with many different organisms playing a role, and
therefore any strategy to clear biofilms would need to target
a component that is widely utilised by different microorganisms in
the biofilm matrix. One possible target that has received
significant interest in recent years is extracellular DNA (eDNA).
The matrices of a many different bacterial and fungal biofilms
contain eDNA, and this molecule has been shown to serve several
critical functions including stabilising the biofilm structure [25–
28], enhancing initial adhesion to surfaces [29,30], promoting the
exchange of genetic information [31], and acting as a nutrient
store that can be utilised during nutrient depletion [32]. Recently,
we have identified an extracellular bacterial deoxyribonuclease,
NucB, from a marine isolate of Bacillus licheniformis strain EI-34-6
that can disperse biofilms by degrading eDNA [33]. The
exogenous addition of NucB to biofilms formed by Escherichia coli,
Bacillus subtilis or Micrococcus luteus resulted in almost complete
removal of bacterial cells from surfaces. Hence, NucB has the
potential to remove biofilms formed by Gram-positive or Gram-
negative bacteria. It is anticipated that the development of new
methods for disrupting viscous biofilm matrices will improve the
post-surgical outcomes of FESS. In addition, such approaches may
facilitate the surgery itself if the obstructive mucin is also targeted.
This study therefore aimed to characterise the potential of NucB to
disperse biofilms formed by microorganisms associated with CRS.
Materials and Methods
Ethics Statement
Ethical approval for the study was granted by the National
Research Ethics Service Committee (North East – Sunderland)
and each patient gave informed consent before enrolment.
Collection of Specimens
A total of 20 patients undergoing FESS for the treatment of
CRS at the Freeman Hospital, Newcastle upon Tyne, were
recruited to this study. All patients met the CRS diagnosis criteria
published by the Chronic Rhinosinusitis Task Force [2]. Patients
were recruited to the study only if obstructive mucin was observed
during the surgical procedure. During FESS, obstructive mucin
that was dislodged surgically was collected with mucous traps
(Sigma Aldrich) and immediately placed into sterile reduced
transport fluid (RTF) [34]. Specimens were transferred to the
laboratory and stored at 4uC. All samples were processed within
24 h.
Transmission Electron Microscope Analysis of Obstructive
Mucin
Samples of obstructive material removed from patients during
FESS were cut into ,1 mm3 pieces and placed into 2%
glutaraldehyde immediately after surgery. These samples were
dehydrated through a series of ethanol washes, embedded and
sectioned at Electron Microscopy Research Services, Newcastle
University. Sections were analysed in a transmission electron
microscope (Philips, CM100).
Visualisation of Bacteria on the Surface of Sinus Mucosa
Fluorescence in situ hybridisation (FISH) was performed using
a peptide nucleic acid (PNA) probe corresponding to the well-
characterised EUB338 probe [35]. The probe was synthesized as
a fluorescein amidite (FAM) conjugate by Panagene. Mucosal
biopsy specimens were fixed in 10% formalin directly after
surgery, and stored at 4uC for up to one month. For PNA-FISH
analysis, specimens were transferred to 50% ethanol and in-
cubated for 16 h at 220uC. Biopsy material was transferred to
1 ml permeabilization buffer (10 mg/ml lysozyme in PBS) and
incubated at 37uC for 30 min. Samples were immersed in 1 ml
pre-warmed wash buffer (10 mM Tris-HCl pH 9.0, 1 mM
EDTA) for 30 min at 55uC. Pre-warmed hybridization buffer
(25 mM Tris-HCl pH 9.0, 100 mM NaCl, 0.5% SDS, 30%
formamide) containing 150 pmol per ml of the PNA probe was
added to samples and incubated in darkness for 90 min at 55uC.
Unbound PNA probe was removed by incubating in pre-warmed
Efficacy of Nuclease against CRS Biofilms
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wash buffer for 30 min at 55uC. Eukaryotic cells were counter-
stained by immersing the specimens in 1 ml PBS containing 2 mg
ml21 49,6-diamidino-2-phenylindole (DAPI) in darkness at 20uC
for 15 min. Samples were glue-mounted onto a plastic surface and
immersed in 2 ml PBS. Visualisation of surface bacteria and
eukaryotic cells was performed using a Leica TCS SP2 microscope
with an argon/neon laser for imaging FAM conjugates (excitation
495 nm, emission 520 nm), and DAPI (excitation 358 nm,
emission 461 nm). Images were converted into z-stacks using
Image J software [36].
Isolation and Culture of Micro-organisms
A variety of growth media were employed for the isolation and
routine culture of micro-organisms. Blood agar contained (per
litre) 37 g Brain Heart Infusion (Oxoid), 5 g Yeast Extract
(Merck), and 15 g Bacteriological Agar. After sterilization, 5%
(v/v) defibrinated horse blood (TCS Biosciences) was added.
Chocolate agar was prepared using the same recipe except that,
after the addition of horse blood, the medium was heated to 70uC
for 10 min. Fastidious Anaerobe Agar (FAA) was purchased from
LabM and Sabouraud Dextrose Agar was from Oxoid.
For isolation of micro-organisms, a portion of sinus aspirate
from each patient was homogenized in sterile phosphate buffered
saline (PBS) and inoculated onto blood agar, chocolate agar, FAA
and two plates of Sabouraud Dextrose agar. Blood and chocolate
agar plates were incubated in 5% CO2 at 37uC. Pre-reduced FAA
plates were incubated at 37uC anaerobically (Ruskinn, Bugbox
Plus) in a gas mix consisting of 10% CO2, 10% H2 and 80% N2.
The Sabouraud Dextrose agar plates were incubated aerobically,
one at 37uC and the other at 30uC. Plates were examined every
24–48 hours for at least seven days. Individual colonies were
picked and sub-cultured three times to obtain pure isolates. Strains
were stored at 280uC in BHY medium [Brain Heart Infusion
37 g/L (Oxoid) and Yeast Extract 5 g/L (Merck)] diluted to 50%
strength by the addition of glycerol.
Identification of Isolates
All isolates were initially characterized by Gram staining,
inspection of colony morphology and testing for catalase pro-
duction, haemolysis and ability to grow aerobically or anaerobi-
cally. A single thick streak of each isolate was plated onto DNase
agar (Oxoid) to test for extracellular nuclease activity. Plates were
incubated aerobically or anaerobically at 37uC for between 24–
96 h. Once colonies had grown, plates were flooded with 4 ml of
0.1% (w/v) toluidine blue (Sigma) to highlight nuclease pro-
duction. The majority of clinical isolates were further identified to
species level using a Matrix Assisted Laser Desorption/Ionization
Time-of-Flight (MALDI-TOF) Mass Spectrometer (Bruker, Mi-
croflex) [37]. Isolates were streaked onto blood agar, incubated
under 5% CO2 or in the absence of oxygen, at 37uC for 24 h and
transferred to the Pathology Department, Freeman Hospital,
Newcastle upon Tyne, for identification.
In cases where MALDI-TOF analysis yielded ambiguous
results, for example the majority of a-haemolytic streptococci,
bacterial identification was confirmed by analysis of the 16S rRNA
gene. Bacteria were cultured in BHY broth, and harvested by
centrifugation at 4,000 g. Cells were resuspended in 150 ml
spheroplasting buffer [26% (w/v) raffinose, 10 mM MgCl2,
20 mM Tris-HCl, pH 6.8] supplemented with 37.5 mg lysozyme
(Sigma) and 50 U mutanolysin (Sigma), and incubated at 37uC for
30 min. Following incubation, DNA was extracted using the
MasterPureTM Gram Positive DNA Purification Kit (EpicentreH
Biotechnologies) in accordance with manufacturer’s instructions.
The DNA was suspended in 25 ml elution buffer (10 mM Tris
pH 8.5).
The gene encoding 16S rRNA was amplified from 2 ml of
extracted DNA in a reaction that also contained 5 ml (25 pmol)
each of oligonucleotide primers 0063F and 1387R [38], 25 ml
ReddyMix Extensor PCR Master Mix (Thermo Scientific) and
13 ml dH20. PCR reactions were run using a GeneAmp PCR
System 9700 (Applied Biosystems) with steps as follows: de-
naturation at 94uC, 2 min, followed by 35 cycles of (i) 94uC,
10 sec, (ii) 55uC, 30 sec, (iii) 68uC, 1 min and a final elongation at
68uC, 7 min. PCR products were checked on a 1% agarose gel,
and fragments of the expected size were sequenced by MWG
Eurofins. Forward and reverse sequences were aligned and
sequence matched using the Ribosomal Database Project website
(http://rdp.cme.msu.edu/).
Purification of B. licheniformis NucB
NucB was produced using a previously described method [33].
Bacterial strain Bacillus subtilis NZ8900 containing plasmid
pNZ8901 was inoculated into 5 ml sterile Luria Bertani broth
(Sigma) containing 5 mg l21 chloramphenicol and cultured
aerobically at 37uC for 18 h. The culture was adjusted to an
optical density (OD600) of 1.0, and 100 mL were transferred to
10 ml of sterile LB containing chloramphenicol and incubated
aerobically at 37uC for 3 h until OD600 ,1.0 was reached. At this
point, 5% v/v cell free supernatant of an overnight B. subtilis
ATCC6633 culture was added to provide the subtilin required to
induce NucB production, and this was incubated for a further
2.5 h. Cells were removed by centrifugation at 6000 g for 20 min
and the supernatant was sterilized by passing through a 0.2 mm
syringe filter. The concentration of NucB was estimated by
comparison with bovine serum albumin standards on a SDS-
PAGE gel. NucB was stored at 4uC for up to 3 months. NucB was
purified from the supernatant using trichloroacetic acid (TCA)
precipitation followed by SuperoseTM 12 gel filtration. Proteins in
the active fractions were further concentrated by TCA pre-
cipitation again and analysed by SDS-PAGE. The concentration
of protein was estimated by densitometry analysis, in comparison
with standards of known concentration [33].
Growth and Biofilm Formation by CRS Isolates
Planktonic growth kinetics in batch culture were measured in
BHY broth. Stock cultures of CRS isolates (see above) were diluted
in BHY to a starting OD600 of ,0.1. Cultures were incubated at
37uC and at hourly intervals, 1 ml samples were removed and
OD600 was determined. For biofilm assays, 8 ml of CRS isolate
stock cultures (see above) were added to triplicate wells of a sterile
polystyrene 96-well plate (Corning 3595) containing 200 ml BHY
broth. The lid was replaced and plates were wrapped in parafilm
and incubated without shaking aerobically at 37uC for 18 h.
Following growth, 150 ml of the non-adherent planktonic cells
were removed and transferred to a clean 96-well plate and the
OD600 was read in a microplate reader (BioTek Synergy HT) to
quantify growth in the planktonic phase. To quantify biofilm
extent, 100 ml of 0.5% (w/v) crystal violet were added to each well
and incubated at 20uC for 15 min. Wells were rinsed 3 times with
200 ml PBS. Residual crystal violet was dissolved in 100 ml 7%
acetic acid and the A570 was read in a microplate reader (BioTek
Synergy HT). Each assay was performed three times indepen-
dently. To assess the efficacy of NucB for dispersing biofilms,
biofilms were cultured as above, and washed three times with PBS.
Purified NucB (3 mg ml21) or PBS alone was added to wells and
incubated for 1 h at 37uC. Remaining biofilms were quantified by
staining with crystal violet.
Efficacy of Nuclease against CRS Biofilms
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Growth and Visualization of Biofilms on Glass Surfaces
The effect of NucB on biofilm architecture was visualized by
confocal laser scanning microscopy (CSLM) or by scanning
electron microscopy (SEM), using biofilms cultured on glass
surfaces. Sterile 13 mm diameter glass coverslips were placed in
wells of a six-well tissue culture plate containing 3 ml BHY. Wells
were inoculated with 50 ml of stock bacterial cultures and
incubated statically in air at 37uC for 18 h. Coverslips were
removed and rinsed three times with PBS, and 1 ml NucB (3 mg
ml21) or 1 ml PBS (control) was added and incubated for 1 h at
37uC. For CSLM, coverslips were inverted onto a rubber O-ring
that had been placed on a microscope slide and filled with Live/
DeadH BacLightTM stain (Molecular Probes). Biofilms were
examined using a Leica TCS SP2 confocal microscope with an
argon/neon laser for visualisation of SYTOH 9 (excitation
485 nm, emission 519 nm), and propidium iodide (excitation
536 nm, emission 617 nm). For SEM, coverslips were fixed in 2%
(v/v) glutaraldehyde at 4uC for 16 h. Specimens were rinsed twice
in PBS and dehydrated through a series of ethanol washes as
follows: 25% ethanol 30 min, 50% ethanol 30 min, 75% ethanol
30 min, and two washes for 1 h in 100% ethanol. Samples were
dried in a critical point dryer (Bal-tec), mounted on aluminium
stubs and sputter coated with gold at Electron Microscopy
Research Services, Newcastle University. Biofilms were visualised
using a scanning electron microscope (Cambridge Stereoscan 240).
Extraction and Analysis of eDNA in Biofilms Formed In
vitro
Bacterial isolates were cultured in 6-well tissue culture dishes
(Greiner) containing 3 ml of BHY broth for 72 h aerobically at
37uC. During this time, broth was carefully removed every 24 h
and replaced with fresh medium. At the end of the 72 h
incubation, medium was removed and PBS (1.5 ml) was added.
Biofilms were gently removed from the surface of the wells using
a plastic tissue culture cell scraper. Cells from four wells were
combined together, and eDNA was purified by a modification of
the method of Kreth et al. [39]. Briefly, cells were mixed by
vortexing for 20 s, and incubated at 37uC for 1 h in the presence
of 5 mg ml21 of Proteinase K (Sigma Aldrich). Cells were
separated from the supernatant, containing eDNA, by centrifuga-
tion at 16,000 g for 2 min. Extracellular DNA in the supernatant
was extracted with phenol:chloroform:isoamyl alcohol (25:24:1).
Samples were centrifuged at 16,000 g for 5 min to separate the
phases, and the aqueous phase was collected. DNA was pre-
cipitated by the addition of isopropanol. The DNA was pelleted by
centrifuging at 16,000 g for 10 min, air dried, and re-suspended in
50 ml of 10 mM Tris pH 8.5. For intracellular DNA, pelleted cells
were resuspended in 150 ml spheroplasting buffer, and DNA was
purified using the method described above.
The concentration and purity of DNA in each fraction was
determined using a NanoDrop spectrophotometer. In addition,
double stranded DNA (dsDNA) was quantified using the Pico-
Green dsDNA reagent (Molecular Probes) and comparing with
standards of known concentration according to the manufacturer’s
instructions. Intracellular and extracellular DNA was visualized by
agarose gel electrophoresis.
Results
Microscopic Analysis of Obstructive Mucin and Mucosal
Biopsies from CRS Patients
Obstructive mucin is sometimes observed in the paranasal
sinuses of CRS patients with or without polyps in the absence of
other symptoms that would indicate fungal rhinosinusitis. The
removal of this mucin from the paranasal sinuses is the
cornerstone of surgical treatment of CRS [40]. This material is
extremely tenacious and removing it significantly extends the
length of time required in the operating theatre. To investigate the
structure of the obstructive mucin, a portion of the material from
two different CRS patients was cut into small pieces (,1 mm3)
immediately after surgery and fixed in glutaraldehyde. The mucin
was embedded and sectioned for TEM analysis (see Materials and
Methods). The material from the two patients appeared similar in
structure, and consisted predominantly of an acellular matrix
either with a striated appearance punctuated by occasional
degraded host cells and cell debris (Figure 1A), or with little
structure and many pockets (Figure 1B). Erythrocytes were
sometimes observed (not shown). However, areas containing large
numbers of eosinophils were not observed in any field of view.
Additionally, bacterial cells and fungi were not seen within the
matrix.
The possibility that microbial cells were present but not directly
observed could not be discounted. Therefore, mucosal biopsies
were also collected from CRS patients, and analysed by confocal
scanning laser microscopy (CSLM). Initially, propidium iodide was
employed to stain bacteria. However, it was difficult to identify
micro-organisms with confidence due to the lack of contrast
between bacteria and host cells. Therefore, in subsequent samples
bacteria were selectively stained by PNA-FISH with the EUB338
probe, and host cells were counterstained with DAPI. Using this
approach, microbial cells were clearly identified on the mucosal
surface (Figure 2). In yz and xz projections, it appeared that most
of the micro-organisms were present in regions above the tissue
surface or in a layer within the top 10 mm of the tissue. A three-
dimensional representation of this image is shown in Figure S1.
The EUB338 PNA probe targets bacterial 16S ribosomal RNA
(rRNA) within metabolically active cells [41]. The detection of
punctate staining with the EUB338 probe is indicative of microbial
cells that were live prior to fixation. In addition to the sharp
staining of cells, there were also patches of fluorescence from the
PNA-FISH probe that were more diffuse (Figure 2B, arrows).
Since PNA probes can hybridize with complementary DNA in
addition to RNA [42], it is likely that this fluorescence represents
extracellular microbial nucleic acids such as RNA or single
stranded DNA.
Isolation and Identification of Micro-organisms
Associated with CRS
Overall, 75 strains of bacteria were isolated from obstructive
mucin, comprising a total of 16 different genera and 32 separate
species (Table 1). The most prevalent organism associated with
CRS aspirates was Staphylococcus epidermidis, which was isolated
from 15 of 20 specimens (75%). Staphylococcus aureus and Streptococcus
spp. were each isolated from 7 patients (35% of samples),
Corynebacterium spp. were isolated from 6 patients (30%), and
Propionibacterium spp. from 5 patients (25%). Other organisms that
were less frequently isolated included Haemophilus influenzae,
Moraxella catarrhalis, Neisseria spp., Finegoldia magna, and Enterobacter
aerogenes. The majority of isolated bacteria were facultative
anaerobes. However, both obligate aerobes (for example, Neisseria
spp. and M. catarrhalis) and obligate anaerobes (F. magna,
Propionibacterium spp.) were also commonly isolated. No fungi were
isolated from any of the patient specimens.
The production of extracellular DNase enzymes by clinical
isolates was assessed using DNase test agar and staining with
toluidine blue. In total, 13 of the 75 isolates (17%) produced
extracellular DNase (Table 1). All S. aureus isolates produced
extracellular DNase, and other producers were Streptococcus
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anginosus group (S. anginosus/S. constellatus/S. intermedius) strains (80%
of strains), Staphylococcus lugdunensis (33% of strains) and Streptococcus
salivarius (33% of strains). Extracellular nuclease producers were
isolated from 11 out of 20 (55%) patients. In only two cases, more
than one nuclease producing organism was isolated from the same
patient sample.
Efficacy of NucB against Biofilm Forming Isolates
Twenty-four bacteria, isolated from patient specimens, were
grown in 96-well microtiter plates to assay for biofilm formation.
Representative strains of all species that produced extracellular
DNase were selected for these studies, along with a similar number
of non-producing organisms. Following incubation for 20 h in
microtitre wells, all isolates had grown in the planktonic phase to
Figure 1. Transmission electron microscopy of obstructive mucin from CRS aspirates. In some cases (A), the mucin either formed a layered
structure, with relatively intact cells towards the outer layers (black arrow) and more degraded cellular material further in (white arrow). (B)
Alternatively, samples had little clear structure and the mucin was punctuated by pockets. The outermost layer of each sample is indicated by dark
arrowheads.
doi:10.1371/journal.pone.0055339.g001
Figure 2. Confocal laser scanning microscopy of surface associated bacteria on mucosa removed from patients diagnosed with
CRS. Bacterial DNA (green) was visualized using an EUB338 PNA-FISH probe, and epithelial cell nuclei (blue) were counterstained with DAPI.
Maximum projection images are shown. In some fields, epithelial cells were observed in the absence of bacteria (A), and in other fields bacterial
biofilm was evident (B). B includes z-stacks oriented from the outside of the mucosal biopsy specimen (labelled ‘top’) to the deeper layers (indicated
by a thick white arrow). Small white arrows indicate patches of diffuse staining, consistent with the presence of extracellular nucleic acids.
doi:10.1371/journal.pone.0055339.g002
Efficacy of Nuclease against CRS Biofilms
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OD600.0.1 with the exception of three strains: S. anginosus FH19,
S. constellatus FH21 and S. pneumoniae FH26 (Table 2). Nevertheless,
all of these strains produced biofilms that were detectable by
crystal violet staining. In fact, S. pneumoniae FH26 produced
a relatively strong biofilm (A570 = 1.87). Growth rates of each strain
in BHY medium were determined in planktonic cultures (Table 2).
No correlation was seen between the maximum growth rate of
strains and the capacity to form biofilms. Generally, there was
extensive variation in the extent of biofilm formation between
different species and between different strains of the same species.
For example, M. catarrhalis FH3 produced a very weak biofilm
(A570 = 0.77), whereas M. catarrhalis FH4 formed extensive biofilms
(A570 = 2.78). Of the strains tested, Streptococcus anginosus FH19
produced the least abundant biofilms (A570 = 0.22). The mean
extent of biofilm formation by non-nuclease producers
(A570 = 1.51, S.E. 0.19, n= 15) was not significantly different from
that of nuclease producers (A570 = 1.48, S.E. 0.32, n = 9).
To assess the importance of eDNA in maintaining the structural
integrity of biofilms, pre-formed biofilms were incubated for 1 h in
the presence of the microbial DNase NucB (Table 2). Biofilms
formed by 9 out of 9 (100%) nuclease producing strains were
significantly reduced by NucB (T test comparing NucB treatment
with buffer control, p,0.05, n= 3). By contrast, only 5 out of 15
(33%) of the biofilms produced by non-nuclease producing
bacteria were dispersed by NucB. In addition, 2 out of 15 (13%)
non-nuclease producers had slightly increased levels of biofilm
following incubation with NucB than without the enzyme. To
assess whether NucB had detrimental effects on the cells
themselves, four different isolates, S. aureus FH7, S. constellatus
FH20, S. salivarius FH29 and M. catarrhalis FH4, were cultured to
mid-exponential phase in THYE broth and challenged with 5 mg
ml21 NucB. These isolates were selected as representative Gram-
positive and Gram-negative organisms to assess the general
toxicity of NucB for bacterial cells. Since the production of
extracellular nucleases by bacteria is widespread, it seemed
unlikely that DNase activity itself would be toxic to bacteria.
Nevertheless, it was important to assess whether the NucB protein
could inhibit the growth of bacteria. No effects were observed on
the growth rate of cells following the challenge (data not shown).
The number of viable cells in each culture continued to increase
following NucB addition, and 1 h after adding NucB there was no
difference in the number of viable cells in cultures containing
NucB compared with control cultures without the enzyme.
Overall, these data suggest that eDNA is an important component
of the EPS for over 50% of the CRS isolates, including strains that
produce extracellular DNase enzymes, and that addition of NucB
dislodges cells without killing or inhibiting bacteria.
Microscopic Analysis of in vitro Grown Biofilms
To obtain more detailed information about the effects of NucB,
biofilms of selected organisms were cultured on glass coverslips
and analysed by CLSM and SEM. This work focussed on
staphylococci and streptococci, since these were the genera most
commonly isolated from CRS patients. In the absence of NucB
treatment, biofilms formed by S. constellatus FH20 were relatively
thin and consisted primarily of a single cell layer that covered most
of the surface (Figure 3). In places, clusters of cells projected from
the surface to a depth of ,12 mm. Using BacLight Live/Dead
stain, both live cells (green) and dead cells (red) were observed in
biofilms. Biofilms that had been treated with NucB were clearly
Table 1. Bacteria isolated from CRS aspirates.
Patient Microbial Species Presenta
Total number of
isolates
1 Enterobacter aerogenes, Staphylococcus epidermidis, Streptococcus sp., Streptococcus pneumoniae, Streptococcus salivarius 5
2 Haemophilus influenzae, Microccus luteus, Staphylococcus epidermis, Staphylococcus hominis, Streptococcus pneumoniae 5
3 Moraxella catarrhalis, Staphylococcus aureus, Streptococcus anginosus 3
4 Klebsiella rhizophila, Staphylococcus epidermidis, Streptococcus constellatus, Streptococcus intermedius, Streptococcus salivarius 5
5 Esherichia coli, Staphylococcus aureus, Staphylococcus epidermidis 3
6 Corynebacterium pseudodiphtheriticum, Finegoldia magna, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus epidermidis,
Staphylococcus lugdunensis
6
7 Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus warneri, Streptococcus constellatus 4
8 Corynebacterium propinquum, Staphylococcus epidermidis, Staphylococcus lugdunensis 3
9 E. aerogenes, Finegoldia magna, Propionibacterium sp., Streptococcus pneumoniae 4
10 Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus epidermidis, Streptococcus pneumoniae 4
11 Staphylococcus epidermidis, Staphylococcus warneri 2
12 Citrobacter koseri, Staphylococcus epidermidis, Propionibacterium sp., Pseudomonas aeruginosa 4
13 Corynebacterium pseudodiphtheriticum, Propionibacterium granulosum, Staphylococcus aureus 3
14 Staphylococcus epidermidis, Staphylococcus pasteuri, Staphylococcus warneri 3
15 Staphylococcus epidermidis, Staphylococcus lugdunensis, Propionibacterium acnes, Propionibacterium granulosum 4
16 Corynebacterium propinquum, Neisseria meningitidis, Staphylococcus aureus 3
17 Neisseria sp., Staphylococcus epidermidis, Streptococcus anginosus, Streptococcus parasanguinis, Streptococcus salivarius 5
18 Staphylococcus aureus, Staphylococcus epidermidis 2
19 Corynebacterium pseudodiphtheriticum, Propionibacterium avidium, Staphylococcus aureus, Staphylococcus epidermidis 4
20 Corynebacterium accolens, Corynebacterium pseudodiphtheriticum, Lactobacillus sp. 3
aStrains highlighted in bold text produced extracellular deoxyribonuclease.
doi:10.1371/journal.pone.0055339.t001
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less extensive than the untreated controls, and consisted of sparsely
distributed single cells or very small aggregates of ,10 cells
(Figure 3B). To obtain higher resolution images, similar biofilms
were analysed by SEM (Figure 4). Again, in the absence of NucB,
cell aggregates were evident and a relatively large proportion of
the surface was covered by micro-organisms (Figure 4A). By
contrast, NucB-treated biofilms almost exclusively contained
isolated cells or small clusters of cells (Figure 4B). In addition,
extracellular material was apparent in untreated biofilms under
high resolution SEM (Figure 4C), that was not seen in biofilms
incubated with NucB (Figure 4D). Biofilms formed on glass
surfaces by S. aureus FH7 or S. intermedius FH22 were also visualised
by SEM (not shown). As with S. constellatus FH20, biofilms that
were treated with NucB contained far less biomass than those
incubated in buffer alone. However, extracellular polymers were
not observed in these organisms.
Quantification of eDNA in Model Biofilms
To quantify levels of eDNA in model biofilms, eDNA and
intracellular DNA (iDNA) was extracted from biofilm cultures of S.
aureus FH7, S. constellatus FH20 and S. salivarius FH29. The eDNA
was analysed by agarose gel electrophoresis (Figure 5). Sharp
bands migrating at an apparent size of 30 kbp were observed in
eDNA fractions of S. aureus FH7 and S. constellatus FH20. However,
no high molecular eDNA bands were seen in S. salivarius FH29.
Intracellular DNA from all three organisms appeared as a smear of
high molecular weight fragments, probably due to binding of
chromosomal DNA to cell wall fragments. In addition to the high
molecular weight fragments, small fragments of DNA or RNA
were seen at the bottom of the gel. Nucleic acids in each fraction
were quantified using the Nanodrop spectrophotometer
(Figure 5B). For each strain, eDNA represented approximately
5–10% of the total DNA present in the biofilm. To account for the
possibility that samples may have contained RNA in addition to
DNA, nucleic acids were also quantified using PicoGreen dye,
which is strongly selective for double stranded DNA. No
significant differences were observed between the total amount
of eDNA in S. salivarius FH29 biofilms and eDNA in biofilms
formed by the other two strains. Therefore, despite the lack of
a clear band by agarose gel electrophoresis, it appears that eDNA
was present in S. salivarius FH29 biofilms.
To assess whether eDNA was present in biofilms formed by
other CRS isolates, biofilms of each strain were cultured in 6-well
plastic dishes and eDNA was purified as described in the Methods
section. Only two strains were omitted from this analysis: S.
constellatus FH21 grew very poorly in biofilms and it was not
possible to extract eDNA, and S. salivarius FH28 was prone to
contamination and, after several attempts, it was decided not to
Table 2. Biofilm formation and NucB sensitivity of selected isolates from CRS aspirates.
Strain
Planktonic Growth
yield OD600 Mean
(S.E.)
Doubling Time
(min) Mean (S.E.)
Biofilm Growth A570
Mean (S.E.)
Nuclease
Productiona
Remaining Biofilm
after NucB Addition
(%) P-value
Corynebacterium propinquum FH1 0.39 (0.06) 235 (11) 1.79 (0.78) 2 105 0.558
Corynebacterium pseudodiphtheriticum FH2 0.86 (0.24) 129 (2) 2.61 (0.43) 2 92 0.577
Moraxella catarrhalis FH3 0.39 (0.07) 232 (6) 0.77 (0.21) 2 127 0.349
Moraxella catarrhalis FH4 0.42 (0.14) 155 (5) 2.78 (0.21) 2 124 0.032
Staphylococcus aureus FH5 0.40 (0.11) 62 (3) 1.84 (0.34) + 77 0.003
Staphylococcus aureus FH6 0.50 (0.08) 74 (0.02) 0.71 (0.12) + 59 0.000
Staphylococcus aureus FH7 0.79 (0.26) 61 (3) 1.23 (0.22) + 40 0.000
Staphylococcus epidermidis FH8 0.27 (0.09) 81 (6) 2.29 (0.41) 2 114 0.077
Staphylococcus epidermidis FH10 0.48 (0.06) 90 (1) 1.59 (0.22) 2 67 0.001
Staphylococcus epidermidis FH11 0.54 (0.13) 104 (4) 1.52 (0.24) 2 74 0.010
Staphylococcus lugdunensis FH12 0.74 (0.03) 73 (4) 1.16 (0.23) 2 49 0.001
Staphylococcus lugdunensis FH13 0.78 (0.05) 70 (0.2) 0.57 (0.10) 2 66 0.001
Staphylococcus lugdunensis FH14 0.78 (0.13) 73 (16) 0.53 (0.05) + 69 0.001
Staphylococcus warneri FH15 0.59 (0.18) 72 (4) 0.89 (0.25) 2 126 0.005
Staphylococcus warneri FH17 0.88 (0.16) 65 (3) 2.40 (0.55) 2 90 0.319
Streptococcus anginosus FH18 0.16 (0.05) 54 (3) 1.16 (0.07) + 34 0.000
Streptococcus anginosus FH19b 0.07 (0.00) 90 (15) 0.22 (0.02) + 59 0.015
Streptococcus constellatus FH20 0.22 (0.04) 103 (28) 1.90 (0.39) + 44 0.001
Streptococcus constellatus FH21b 0.04 (0.03) NDc 0.31 (0.05) 2 39 0.001
Streptococcus intermedius FH22 0.19 (0.02) 67 (2) 3.07 (0.80) + 46 0.000
Streptococcus pneumoniae FH26 0.07 (0.03) 56 (1) 1.87 (0.31) 2 123 0.585
Streptococcus salivarius FH27 0.20 (0.06) 37 (3) 0.99 (0.04) 2 92 0.240
Streptococcus salivarius FH28 0.32 (0.04) 111 (29) 2.67 (0.96) + 66 0.002
Streptococcus salivarius FH29 0.23 (0.03) 39 (0.7) 1.08 (0.04) 2 96 0.692
aProduction of nuclease was measured on DNase agar, and is indicated by a ‘+’ sign.
bIsolates grew poorly in both the planktonic and biofilm phase.
cND, not determined.
doi:10.1371/journal.pone.0055339.t002
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pursue DNA purification from this strain. By agarose gel
electrophoresis, sharp bands corresponding to high molecular
weight eDNA products were observed in all Staphylococcus spp., S.
constellatus FH20 and in S. intermedius FH22 (Figure 5C). By
contrast, similar bands were not detected from Corynebacterium spp.,
S. anginosus or S. pneumoniae. Only M. catarrhalis and S. salivarius had
inter-strain differences in the production of eDNA. Thus, eDNA
was not visualised in M. catarrhalis FH3 biofilm extracts, whereas
eDNA was clearly present in M. catarrhalis FH4 (Figure 5C).
Similarly S. salivarius FH29 did not produce a band of eDNA on an
agarose gel, whereas a sharp band was seen in S. salivarius FH27.
The concentrations of eDNA in samples were determined using
the Nanodrop spectrophotometer. Concentrations of eDNA in the
extracts ranged from 206 ng ml21 to 917 ng ml21 (Figure 5C).
Interestingly, there appeared to be little correlation between the
concentration of eDNA and the presence or absence of a band on
the agarose gel. For example, M. catarrhalis FH3 produced one of
the highest concentrations of eDNA, but no band on the gel.
Conversely, the eDNA concentration from S. intermedius FH22 was
just 325 ng ml21 even though this strain clearly produced a band
of eDNA on a gel. The production of an extracellular nuclease did
not correlate with the presence of a band of eDNA on a gel. All
strains of S. aureus (nuclease-positive) and S. epidermidis (nuclease-
negative) produced clear bands of eDNA, for example. With the
exception of S. anginosus FH18 and S. anginosus FH19, all strains
that failed to produce a clear band of eDNA on an agarose gel
were insensitive to NucB treatment.
Discussion
There is mounting evidence that microbial biofilms growing
within paranasal sinuses are a major factor in the pathogenesis of
CRS [14]. Bacterial biofilms have been most commonly detected
on the sinus mucosa, whereas fungi tend to be more easily detected
within the sinonasal mucous. Fungal growth is often accompanied
by mucous secretions containing large numbers of intact or
degraded eosinophils, known as ‘eosinophilic mucin’ or ‘allergic
mucin’ [43–45]. The eosinophils appear to migrate intact from the
tissues, and degrade or degranulate upon reaching the mucin,
possibly in order to target fungi growing within the mucin. Allergic
mucin may be present in the absence of fungi [46]. In our
experience, a number of patients present with thick, tenacious
mucin obstructing the paranasal sinsues, but without other
evidence of fungal rhinosinusitis. We hypothesized that bacterial
biofilms may contribute to the pathogenesis of CRS in these
patients. The aim of this study was to characterize the microflora
in paranasal sinuses of patients with obstructive mucin, and to
assess the potential of a novel deoxyribonuclease enzyme for
degrading biofilms formed by isolated micro-organisms.
Initially, the structure of obstructive mucin was investigated
using TEM. This material contained relatively small numbers of
degraded host cells. Therefore, this structure appears to be
different from eosinophilic mucin [44]. In addition, fungi were not
observed either by high-resolution TEM of obstructive mucin or
by culture. The role of fungi in CRS is currently unclear. Culture-
based studies have reported very low rates of isolation of fungi
from CRS samples [20,22], whereas the direct microscopic
analysis of eosinophilic mucin in some cases detects fungi in
100% of patient samples [45]. In the patient cohort analysed here,
CRS appeared to be of a non-fungal aetiology. Bacterial cells were
also not detected within the obstructive mucin. However, bacteria
do not generally produce filamentous structures such as hyphae
and can be difficult to detect in thin sections. By carefully
examining the mucosal surfaces, bacterial biofilms could be
observed. Bacteria appeared to be localised on top of the tissue
or within the outer layer of epithelial cells. It is likely that the
dehydration steps involved in sample processing for FISH would
have compromised the outer barrier of the tissue, leading to an
irregular surface and the appearance of bacterial nucleic acid
staining in regions slightly below the surface of the tissue.
Alternatively, a proportion of the bacterial cells may have been
present within the host cytoplasm, as has previously been
described for S. aureus [47]. Nevertheless, the structure of biofilms
was consistent with those previously described in CRS patients [9].
In addition, more than one species of bacterium was isolated from
each of the 20 samples tested.
In total, 75 strains of bacteria were isolated from 20 CRS
patients. On the whole, the organisms identified in this study were
very similar to those identified in previous culture-based investiga-
tions into the microflora of CRS patients. Thus, staphylococci
(both S. aureus and coagulase-negative staphylococci) and a-
haemolytic streptococci were the most commonly isolated
Figure 3. Confocal laser scanning microscopy of Streptococcus constellatus FH20 biofilms with or without NucB treatment. Biofilms
were formed on glass surfaces and were visualised with CLSM using BacLight LIVE/DEAD stain, which stains compromised (dead) cells red and live
cells green. (A) Biofilms treated with buffer alone, and (B) biofilms treated with NucB.
doi:10.1371/journal.pone.0055339.g003
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organisms, in agreement with published reports [18,20–22].
Corynebacteria were isolated from seven CRS patients, and
several potential pathogens were identified, includingM. catarrhalis,
Neissseria spp. and H. influenzae. All of these species have been
isolated from CRS cases. However, their contribution to disease
pathogenesis is unclear [20,22]. Enterobacteriaciae have been
frequently isolated from CRS patients [20–22], and this group
of organisms was represented here by C. koseri, E. aerogenes, E. coli,
and K. pneumoniae. There has been some debate about the presence
of obligate anaerobes in paranasal sinuses of CRS patients. Thus,
Doyle et al. [22] did not isolate anaerobes from chronic ethmoid
sinusitis, whereas Brook [21] found that obligate anaerobes formed
the majority of the bacteria isolated from chronic maxillary
sinusitis. It is possible that the maxillary sinuses provide a more
conducive environment for the growth and survival of anaerobes
than the ethmoid sinuses. Here, samples were collected from
a mixture of maxillary, sphenoid and ethmoid sinuses, and
obligate anaerobes (Propionibacterium spp. or F. magna) were isolated
from 6 of the 20 patients. The micro-organisms isolated and
identified in this investigation are representative of the culturable
microflora common in CRS patients. Recently, it has been shown
that culture-independent, pyrosequencing analysis of the CRS
microflora identifies a very similar microflora to that found by
culture, although pyrosequencing has greater sensitivity for
detecting difficult-to-culture or low-abundance micro-organisms
[48].
The capacity of micro-organisms to form biofilms is likely to be
important for the colonization of paranasal sinuses. Several studies
have now provided direct evidence that bacteria are commonly
present in biofilms on sinus mucosa in CRS patients [14].
Figure 4. Scanning electron microscopy of Streptococcus constellatus FH20 biofilms treated with NucB or buffer control. Biofilms were
visualised with SEM after treatment for 1 h with buffer (A) or with NucB (B). At higher magnification, extracellular material (white arrow) was observed
in the absence of NucB treatment (C), but was not seen in NucB-treated biofilms (D).
doi:10.1371/journal.pone.0055339.g004
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Nevertheless, little is known about whether these organisms are
particularly well-suited to forming biofilms. The ability of biofilm
bacteria on sinus mucosa to produce biofilms in vitro has been
assessed by directly inoculating mucosal swabs into a Calgary
biofilm device model [49]. P. aeruginosa biofilm-defective mutants
(sad-31 and sad-36) were separately set up in the model to set the
threshold value, below which samples were designated as non-
biofilm formers. Using these criteria, 28.6% of 157 sinus aspirate
samples produced biofilms. However, this is likely to be
a significant underestimate of the total biofilm-forming capacity
of mucosal bacteria since the biofilm experiments used only Luria-
Bertani broth incubated aerobically, and therefore anaerobic or
fastidious micro-organisms would not have grown. The capacity of
clinical isolates of P. aeruginosa, S. aureus and coagulase-negative
staphylococci, isolated .1 year post-FESS treatment, to form
biofilms has been assessed as a possible predictor of the long-term
outcomes of treatment [17]. Over 50% of strains tested produced
biofilms, and the ability of P. aeruginosa or S. aureus to form biofilms
appeared to be correlated with a poor clinical evolution of disease.
To the best of our knowledge, there have been no investigations
into the biofilm-forming ability of bacteria freshly isolated from
patients during CRS treatment. We aimed to establish whether
isolated CRS bacteria form biofilms in vitro and, further, whether
eDNA contributes to the integrity of the biofilm.
In total, 24 isolated strains were tested for biofilm formation in
a microplate model system, and all strains produced biofilms to
some extent. The ability to form biofilms was not closely related to
the growth rate or yield in planktonic cultures. These data are in
line with previous studies on Listeria monocytogenes or Salmonella
enterica strains, which also found no correlation between the growth
rate or yields of individual strains and their capacities to form
biofilms in microplate model systems [50,51]. Representative
Figure 5. The visualization and quantification of eDNA from CRS isolates. (A) Intracellular DNA (i) or eDNA (e) was purified from bacterial
biofilms of S. aureus FH7, S. constellatus FH20 or S. salivarius FH29, and analysed by agarose gel electrophoresis. High molecular weight chromosomal
DNA is indicated by a black bracket; low molecular DNA or RNA is highlighted at the bottom of the gel by a black arrow. M; size marker. (B) The
concentration of DNA in the intracellular (grey bars) and extracellular (white bars) fractions from bacterial biofilms was measured by NanoDrop
spectrophotometry. Bars represent means of three independent extracts, and SEs are indicated. (C) Extracellular DNA concentration in biofilms was
also visualised for another 19 isolates (see Table 1 for species names). In many cases, distinct bands were observed with an apparent migration at
approximately 30 kbp. The total DNA concentration was measured by NanoDrop spectrophotometry, bars represent the average of three replicates
and error bars are S.E.
doi:10.1371/journal.pone.0055339.g005
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strains of many of the species found in this study have been shown
to produce DNase I-sensitive biofilms including, for example, S.
aureus [52,53], S. pneumoniae [54,55], Neisseria spp. [56,57], P.
aeruginosa [29] and E. coli [53]. We have recently identified a novel
DNase enzyme, NucB, from a marine strain of Bacillus licheniformis
that has potent anti-biofilm activity against a number of bacteria
including E. coli and M. luteus [33]. This enzyme is smaller in size
(,12 kDa) than many other nucleases, including DNase I, and
appears to be well adapted to breaking up bacterial biofilms even
at low concentrations [33]. A key goal of this study was to establish
whether freshly isolated CRS-associated bacteria produce biofilms
that are sensitive to NucB. Overall, .50% of the strains tested
produced biofilms that were reduced upon treatment with NucB.
In fact, the vast majority of staphylococci (8 of 10 strains tested)
and streptococci (6 of 9 strains) produced NucB-sensitive biofilms.
In contrast, two Corynebacterium spp. and two M. catarrhalis strains
made biofilms that were not removed by NucB. In one case the M.
catarrhalis biofilm was slightly, but significantly, increased by NucB
treatment. Whilst eDNA commonly promotes adhesion and
biofilm formation by bacteria, in rare cases eDNA has been
shown to inhibit bacterial settlement [58]. It is possible that eDNA
may be inhibitory to M. catarrhalis adhesion and that NucB-
mediated eDNA degradation would therefore promote adhesion
by this organism. This hypothesis requires further investigation.
The production of extracellular DNase enzymes by bacteria
may influence the structure of biofilms. For example, isogenic
nuclease-deficient mutants of S. aureus, Neisseria gonorrhoeae or Vibrio
cholerae form thicker biofilms than their wild-type progenitor strains
[57,59,60]. However, using in vitro or in vivo models of catheter
biofilms, Beenken et al. [61] found that the total number of viable
cells in biofilms of the clinical osteomyelitis isolate S. aureus UAMS-
1 was not affected by mutation in either of two extracellular
nuclease-encoding genes. Therefore, it is not clear whether
microbial nucleases contribute to the gross biofilm structure in
clinically relevant situations. Production of extracellular DNase
enzymes has been reported for several of the genera isolated here.
S. aureus is well-known to produce DNases, and DNase production
is often used as a phenotypic test to differentiate S. aureus from
coagulase-negative staphylococci. However, the test must be
interpreted with caution, since some coagulase-negative staphylo-
cocci such as S. lugdunensis can produce nucleases [62]. In fact, one
of the S. lugdunensis strains isolated here was found to produce
DNase. Corynebacterium diphtheriae and N. gonorrhoeae have also been
reported to be able to produce extracellular DNase enzymes
[57,63], but DNases were not detected in any of the Corynebacterium
spp. or Neisseria spp. identified in this study. Production of DNases
is variable in a-haemolytic streptococci [64], and 5 of the 9
streptococci isolated here produced DNase activity. Representa-
tive strains of all species that produced nuclease were tested in
biofilm assays. Interestingly, all 9 nuclease-producing strains made
biofilms that were reduced by treatment with the exogenous
addition of NucB. These data provide clear evidence that the
ability of a strain to produce extracellular nucleases does not
preclude the formation of biofilms that are stabilised by eDNA.
The production of extracellular DNases is tightly regulated in
bacteria. For example, in S. aureus, nuclease production is
regulated by the stress response sigma factor B [59]. Within
biofilms, nucleases may be produced at low levels or by only a small
proportion of the cells.
Here, direct evidence for the presence of eDNA in biofilms
formed by 22 CRS isolates was provided by extraction and
quantification of eDNA. All strains produced significant amounts
of eDNA that could easily be measured in the Nanodrop
spectrophotometer. A more detailed analysis was conducted on
three different CRS isolates, including two that produce nucleases
(S. aureus FH7 and S. constellatus FH20). In S. constellatus FH20
biofilms, extracellular material was observed by SEM (Figure 4).
Extracellular DNA purified from S. aureus FH7 and S. constellatus
FH20 biofilms was visualised as sharp high molecular weight
bands on agarose gels with an apparent migration similar to that of
intracellular chromosomal DNA. However, eDNA from S.
salivarius FH29 was not detected by this technique. Nevertheless,
quantitative measures indicated that extracellular nucleic acids
were present in S. salivarius FH29 biofilms. Interestingly, in
contrast to S. aureus FH7 and S. constellatus FH20, S. salivarius FH29
biofilms were not sensitive to NucB. Therefore, it appears that S.
salivarius FH29 does not rely on large fragments of eDNA to
stabilise biofilms. A broader analysis of the CRS isolates identified
six other strains that did not produce defined bands of eDNA
when analysed on agarose gels. Of these, four strains were
insensitive to NucB indicating that, like S. salivarius FH29, these
strains do not utilise large eDNA fragments for biofilm stabilisa-
tion. The two strains of S. anginosus did not produce visible bands of
eDNA on gels, even though both strains were sensitive to NucB. It
is possible that eDNA from S. anginosus was partially degraded, to
the point where it did not form a defined band on a gel, but was
still present in sufficient quantities to be utilised for maintaining
the biofilm structure.
Improving the surgical treatment of CRS requires new methods
for controlling microbial biofilms in the paranasal sinuses. The
data presented here demonstrate that many CRS-associated
bacteria produce biofilms that can be reduced by treatment with
a microbial nuclease NucB in vitro. Given the high prevalence of
CRS, even a 50% reduction in the colonization of sinus mucosa by
micro-organisms would be predicted to have significant clinical
benefits on a population level. Of course, the current study has
focussed on in vitro work and it is acknowledged that translating the
findings to the clinic will require further investigations in animal
models and ultimately in patients. Before this can be done, the
safety of NucB for clinical use must be established. We are
currently in the process of testing the safety of NucB with a view to
conducting clinical trials in future. In addition, it would be
interesting to determine whether matrix-degrading enzymes act
synergistically with antibiotics to control biofilm growth since this
would present additional therapeutic possibilities. Ultimately, the
utility of DNase enzymes to aid the treatment of CRS will depend
upon in vivo data. Nevertheless, we have shown that NucB has
clear potential for the control of biofilms formed by clinically
important strains of bacteria.
Supporting Information
Figure S1 Three-dimensional rotation showing micro-organisms
associated with the outer layer of a mucosal biopsy. Bacterial DNA
was hybridized with the EUB338 PNA-FISH probe, and appears
green in the image. Host cell nuclei were counterstained blue.
Bacterial cells (punctate green staining) are seen interacting with
cells on the surface of the biopsy.
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